Literature DB >> 1821662

Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure.

M J Fulham1, R M Dubinsky, R J Polinsky, R A Brooks, R T Brown, M T Curras, S Baser, M Hallett, G Di Chiro.   

Abstract

We studied 45 patients who had autonomic failure with computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose to characterize the neuroimaging features of multiple system atrophy and pure autonomic failure and determine the utility of these techniques in distinguishing multiple system atrophy from pure autonomic failure. There were 30 patients with multiple system atrophy and 15 with pure autonomic failure. In the multiple system atrophy group, eight patients had mainly cerebellar signs, seven extrapyramidal and 15 had combinations of cerebellar and extrapyramidal signs. Cerebellar atrophy on computerized tomography and magnetic resonance imaging, signal hypointensity in the posterolateral putamen on magnetic resonance imaging and a generalized reduction in glucose utilization rate with positron emission tomography with [18F]fluorodeoxyglucose, were the main findings and were seen only in the patients with multiple system atrophy. Decreased glucose utilization (hypometabolism) was most prominent in the cerebellum, brainstem, striatum and frontal and motor cortices. These results indicate clear differences, using neuroimaging studies, between multiple system atrophy and pure autonomic failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821662     DOI: 10.1007/BF01826055

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  33 in total

1.  Degenerative diseases of the nervous system associated with autonomic failure.

Authors:  R Bannister; D R Oppenheimer
Journal:  Brain       Date:  1972       Impact factor: 13.501

2.  Cerebral glucose metabolism in Parkinson's disease.

Authors:  W R Martin; J H Beckman; D B Calne; M J Adam; R Harrop; J G Rogers; T J Ruth; C I Sayre; B D Pate
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

3.  The splanchnic autonomic outflow in Shy-Drager syndrome and idiopathic orthostatic hypotension.

Authors:  P A Low; J E Thomas; P J Dyck
Journal:  Ann Neurol       Date:  1978-12       Impact factor: 10.422

4.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.

Authors:  D E Kuhl; E J Metter; W H Riege
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

5.  Pharmacologic distinction of different orthostatic hypotension syndromes.

Authors:  R J Polinsky; I J Kopin; M H Ebert; V Weise
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

6.  Dysautonomia in Parkinsonism: a clinicopathological study.

Authors:  A H Rajput; B Rozdilsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

7.  Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors.

Authors:  G Di Chiro; R A Brooks; N J Patronas; D Bairamian; P L Kornblith; B H Smith; L Mansi; J Barker
Journal:  Ann Neurol       Date:  1984       Impact factor: 10.422

8.  Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography.

Authors:  S Gilman; D S Markel; R A Koeppe; L Junck; K J Kluin; S S Gebarski; R D Hichwa
Journal:  Ann Neurol       Date:  1988-03       Impact factor: 10.422

9.  MR imaging in progressive supranuclear palsy and Shy-Drager syndrome.

Authors:  M Savoiardo; L Strada; F Girotti; L D'Incerti; M Sberna; P Soliveri; L Balzarini
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

10.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

View more
  8 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 2.  Functional imaging with positron emission tomography in multiple system atrophy.

Authors:  S Gilman
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.575

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  The classification and nomenclature of autonomic disorders--ending chaos, resolving conflict and hopefully achieving clarity.

Authors:  C J Mathias
Journal:  Clin Auton Res       Date:  1995-12       Impact factor: 4.435

5.  Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.

Authors:  M Ghaemi; R Hilker; J Rudolf; J Sobesky; W-D Heiss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

6.  Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria.

Authors:  A Albanese; C Colosimo; A R Bentivoglio; R Fenici; G Melillo; C Colosimo; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

7.  Comprehensive Functional Evaluation of the Spectrum of Multi-System Atrophy with 18F-FDG PET/CT and 99mTc TRODAT-1 SPECT: 5 Year's Experience from a Tertiary Care Center.

Authors:  Nikhil Seniaray; Ritu Verma; Rajeev Ranjan; Ethel Belho; Harsh Mahajan
Journal:  Ann Indian Acad Neurol       Date:  2021-05-21       Impact factor: 1.383

Review 8.  The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

Authors:  Gregor K Wenning; Iva Stankovic; Luca Vignatelli; Alessandra Fanciulli; Giovanna Calandra-Buonaura; Klaus Seppi; Jose-Alberto Palma; Wassilios G Meissner; Florian Krismer; Daniela Berg; Pietro Cortelli; Roy Freeman; Glenda Halliday; Günter Höglinger; Anthony Lang; Helen Ling; Irene Litvan; Phillip Low; Yasuo Miki; Jalesh Panicker; Maria Teresa Pellecchia; Niall Quinn; Ryuji Sakakibara; Maria Stamelou; Eduardo Tolosa; Shoji Tsuji; Tom Warner; Werner Poewe; Horacio Kaufmann
Journal:  Mov Disord       Date:  2022-04-21       Impact factor: 9.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.